Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $316.69 | 7 | 44.0% |
| Honoraria | $300.00 | 2 | 41.7% |
| Education | $102.79 | 6 | 14.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $300.00 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $196.94 | 6 | $0 (2024) |
| PFIZER INC. | $140.47 | 3 | $0 (2022) |
| TESARO, Inc. | $41.66 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $16.69 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.62 | 2 | E.R. Squibb & Sons, L.L.C. ($42.62) |
| 2022 | $21.00 | 1 | PFIZER INC. ($21.00) |
| 2021 | $144.48 | 4 | E.R. Squibb & Sons, L.L.C. ($111.56) |
| 2019 | $300.00 | 2 | Alexion Pharmaceuticals, Inc. ($300.00) |
| 2017 | $211.38 | 6 | PFIZER INC. ($98.47) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $21.31 | General |
| Category: Oncology | ||||||
| 01/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $21.31 | General |
| Category: Oncology | ||||||
| 10/03/2022 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $105.31 | General |
| Category: Oncology | ||||||
| 07/21/2021 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2021 | E.R. Squibb & Sons, L.L.C. | — | Education | In-kind items and services | $6.25 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 09/11/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 06/27/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 04/11/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.62 | General |
| Category: Oncology | ||||||
| 03/30/2017 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $98.47 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Oncology | ||||||
| 02/14/2017 | TESARO, Inc. | VARUBI (Drug) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 659 | 1,214 | $184,176 | $47,928 |
| 2022 | 5 | 454 | 695 | $259,963 | $59,267 |
| 2021 | 5 | 434 | 670 | $244,792 | $60,259 |
| 2020 | 17 | 719 | 1,363 | $243,211 | $59,943 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 161 | $53,879 | $14,115 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 76 | $38,818 | $10,778 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 41 | $26,223 | $7,275 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 47 | 60 | $19,500 | $4,069 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $16,764 | $3,788 | 22.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 90 | 238 | $4,712 | $1,999 | 42.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 173 | $5,363 | $1,317 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $4,972 | $1,192 | 24.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 32 | 85 | $3,655 | $879.75 | 24.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 25 | 44 | $2,420 | $587.84 | 24.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 11 | 45 | $1,710 | $410.12 | 24.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 18 | 61 | $1,586 | $386.74 | 24.4% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 23 | 30 | $1,560 | $375.00 | 24.0% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 24 | 45 | $1,080 | $266.40 | 24.7% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 18 | 61 | $854.00 | $226.92 | 26.6% |
| 83540 | Iron level | Office | 2023 | 23 | 30 | $780.00 | $190.20 | 24.4% |
| 84155 | Total protein level, blood | Office | 2023 | 16 | 20 | $300.00 | $72.00 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 354 | $111,962 | $24,559 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 63 | 63 | $37,659 | $8,619 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 70 | $30,800 | $8,152 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 87 | 108 | $34,630 | $8,056 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $15,586 | $3,536 | 22.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $11,412 | $2,266 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $8,131 | $1,848 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 12 | $5,326 | $1,211 | 22.7% |
About Dr. Han-Ting Lin, MD
Dr. Han-Ting Lin, MD is a Hematology healthcare provider based in Salem, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114019148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Han-Ting Lin, MD has received a total of $719.48 in payments from pharmaceutical and medical device companies, with $42.62 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($316.69).
As a Medicare-enrolled provider, Lin has provided services to 2,266 Medicare beneficiaries, totaling 3,942 services with total Medicare billing of $227,398. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Salem, NH
- Active Since 09/28/2006
- Last Updated 12/30/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114019148
Products in Payments
- Soliris (Drug) $300.00
- OPDIVO (Biological) $190.69
- XTANDI (Drug) $98.47
- ORGOVYX (Drug) $42.00
- VARUBI (Drug) $41.66
- Stivarga (Drug) $16.69
- GILOTRIF (Drug) $11.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.